| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.288 | 24.445 | 34.956 | 50.118 | 19.322 | 97.027 | 151.917 |
| Total Income - EUR | - | - | - | 3.288 | 24.445 | 34.956 | 50.118 | 19.322 | 97.027 | 151.917 |
| Total Expenses - EUR | - | - | - | 12 | 860 | 1.095 | 949 | 2.507 | 18.490 | 45.279 |
| Gross Profit/Loss - EUR | - | - | - | 3.276 | 23.585 | 33.861 | 49.170 | 16.815 | 78.537 | 106.639 |
| Net Profit/Loss - EUR | - | - | - | 3.178 | 22.852 | 32.886 | 47.930 | 16.621 | 77.586 | 102.081 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Aniagyn S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 26 | 26 | 25 | 25 | 25 | 18.548 | 124.554 |
| Current Assets | - | - | - | 3.508 | 23.131 | 33.766 | 69.616 | 16.745 | 67.346 | 1.891 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 5.588 | 23.977 | 42.772 | 10.263 | 1.874 | 482 |
| Cash | - | - | - | 3.508 | 17.544 | 9.789 | 26.845 | 6.483 | 65.472 | 1.408 |
| Shareholders Funds | - | - | - | 3.221 | 22.902 | 32.935 | 47.979 | 16.670 | 84.041 | 123.311 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 314 | 255 | 856 | 21.662 | 100 | 1.853 | 3.134 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Aniagyn S.r.l.